Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome

Eva Delpón1, Jonathan M Cordeiro, Lucía Núñez

  • 1Department of Pharmacology, School of Medicine, Universidad Complutense, Madrid, Spain.

Abstract

Insights

Mutations in the KCNE3 gene are linked to Brugada Syndrome (BrS), a condition causing sudden cardiac arrest. This study identifies a specific KCNE3 mutation affecting the transient outward current (I(to)) in heart cells.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Brugada Syndrome (BrS) is an inherited disorder linked to sudden cardiac arrest.
  • Mutations in ion channel genes cause loss of function in sodium and calcium channels.
  • Transient outward current (I(to)) is implicated in BrS, but I(to)-related gene mutations were previously unidentified.

Purpose of the Study:

  • To screen for ion channel gene mutations in Brugada Syndrome (BrS) patients.
  • To investigate the functional role of KCNE3 mutations in the development of BrS.
  • To analyze the impact of KCNE3 mutations on transient outward current (I(to)) in cardiac cells.

Main Methods:

  • Screening of 105 BrS probands for ion channel gene mutations using SSCP electrophoresis and sequencing.
  • Co-transfection of wild-type (WT) or mutant KCNE3 with KCND3 or KCNQ1 in CHO-K1 cells.
  • Whole-cell patch clamp studies and co-immunoprecipitation experiments on human atrial samples.

Main Results:

  • A missense mutation (R99H) in KCNE3 (MiRP2) was identified in one BrS proband and affected family members.
  • Co-transfection of R99H-KCNE3 with KCND3 significantly increased I(to) intensity compared to WT KCNE3.
  • Kv4.3 and KCNE3 were shown to co-immunoprecipitate in human atrial tissues, indicating interaction.

Conclusions:

  • KCNE3 plays a functional role in modulating I(to) in the human heart.
  • Mutations in KCNE3 are suggested as a cause for Brugada Syndrome.
  • This finding identifies a novel genetic basis for BrS.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...